V6 - SARS-CoV-2 / Influenza A/B / RSV/ ADV/ hMPV Antigen Combo Test Kit

General information: COVID-19 is an acute respiratory infectious disease caused by SARS-CoV-2. The main manifestations include fever, fatigue and dry cough. Other symptoms might be nasal congestion, runny nose, sore throat, myalgia and diarrhea. Currently, the patients infected by the novel coronavirus are the main source of infection. Asymptomatic infected people can also be an infectious source. Influenza (flu) is a contagious respiratory illness caused by influenza viruses. Influenza viruses can cause mild to severe illness. Some specific populations, such as the elderly, young children, and people with certain underlying health conditions, are at higher risk of developing serious flu complications. There are two main types of influenza viruses: type A and B. Both type A and B influenza viruses regularly spread in people, and are responsible for seasonal flu each year. Respiratory syncytial virus (RSV) can be spread by coughing and air droplets, mainly causing lower respiratory tract infections, such as bronchiolitis and pneumonia, in infants under 6 months of age, and upper respiratory tract infections, such as rhinitis and the common cold, in older children and adults, and bronchitis or pneumonia in the elderly. Adenoviruses (ADV) can infect humans, and they can infect the respiratory tract, gastrointestinal tract, urinary tract and bladder, eye, liver, etc. About 1/3 of the known serotypes of human adenovirus are commonly associated with human diseases. Human Metapneumo virus ( hMPV) causes mostly a mild self-limited disease. Some patients require hospitalization due to complications such as bronchiolitis, pneumonia, acute exacerbation of chronic obstructive pulmonary disease (COPD), and acute exacerbation of bronchial asthma. Intended use: The fluorecare SARS-CoV-2 & Influenza A/B & RSV/ ADV/ hMPV Antigen Combo Test Kit is applicable to the simultaneous qualitative detection and differentiation in vitro of novel Coronavirus (SARS-CoV-2) antigen, Influenza A virus antigen, Influenza B virus antigen, RSV antigen, Adenovirus (ADV) antigen, Human Metapneumo virus (hPMV) antigen in Oropharyngeal swab, Nasal swab and Nasopharyngeal swab samples. Advantages: Quick results - within 12 minutes Easy to use - in just 3 quick steps Possibility of using nasal samples All necessary reagents provided (individually packaged) High sensitivity and specificity Principle: The SARS-CoV-2 / Influenza A/B / RSV / Adenovirus / hMPV Antigen Combo Test Kit is a qualitative test to detect SARS-CoV-2 & Influenza A/B Antigen/ RSV/ ADV/ hMPV Antigen in samples by the colloidal gold chromatographic immunoassay method. After the treated sample solution is applied to the test card, the SARS-CoV-2 Antigen (or Influenza A/B & RSV / ADV / hMPV) in the collected sample will be combined with the SARS-CoV-2 (or Influenza A/B & RSV / ADV / hMPV) antibody labeled with colloidal gold on the conjugate pad to form a SARS-CoV-2 Antigen (or Influenza A/B & RSV / ADV / hMPV)-antibody-colloidal gold complex. Due to chromatography, the SARS-CoV-2 Antigen (or Influenza A/B & RSV / ADV / hMPV)-antibody-colloidal gold complex diffuses along the nitrocellulose membrane. Within the detection line (T) region, the SARS-CoV-2 Antigen (or Influenza A/B & RSV / ADV / hMPV ) complex will be captured by the antibody enclosed within the detection line region, showing a purple band. When colloidal gold-labeled SARS-CoV-2 (or Influenza A/B & RSV/ ADV/ hMPV) complex diffuses to the quality control line (C) region, it will be captured by goat anti-mouse IgG to form a purple band. When the reaction is over, the results can be interpreted by visual observation. Materials Provided: Test cards (individually packaged) Sterile nasal swabs (individually packaged) Sample treatment solution (individual) Instructions for use CE certificate